Shaanxi Kanghui Pharmaceutical Co Ltd
SSE:603139

Watchlist Manager
Shaanxi Kanghui Pharmaceutical Co Ltd Logo
Shaanxi Kanghui Pharmaceutical Co Ltd
SSE:603139
Watchlist
Price: 20.78 CNY -0.19% Market Closed
Market Cap: 2.1B CNY

Wall Street
Price Targets

Price Targets Summary
Shaanxi Kanghui Pharmaceutical Co Ltd

There are no price targets for Shaanxi Kanghui Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shaanxi Kanghui Pharmaceutical Co Ltd Competitors:
Price Targets
4151
Kyowa Kirin Co Ltd
5% Upside
TBPH
Theravance Biopharma Inc
43% Upside
603566
Pulike Biological Engineering Inc
34% Upside
002821
Asymchem Laboratories Tianjin Co Ltd
19% Upside
AMRX
Amneal Intermediate Inc
10% Upside
6996
Antengene Corporation Ltd
76% Upside
086450
Dongkook Pharmaceutical Co Ltd
51% Upside
COHANCE
Cohance Lifesciences Ltd
74% Upside

Revenue
Forecast

Revenue Estimate
Shaanxi Kanghui Pharmaceutical Co Ltd

For the last 9 years the compound annual growth rate for Shaanxi Kanghui Pharmaceutical Co Ltd's revenue is 4%. The projected CAGR for the next 6 years is -31%.

4%
Past Growth
-31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Shaanxi Kanghui Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Shaanxi Kanghui Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Shaanxi Kanghui Pharmaceutical Co Ltd

Net Income forecast
is not available for
Shaanxi Kanghui Pharmaceutical Co Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shaanxi Kanghui Pharmaceutical Co Ltd's stock price target?
Not Available

Shaanxi Kanghui Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shaanxi Kanghui Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-31%

For the last 9 years the compound annual growth rate for Shaanxi Kanghui Pharmaceutical Co Ltd's revenue is 4%. The projected CAGR for the next 6 years is -31%.

Back to Top